retatrutide type 2 diabetes trial results 2024 phase 2 VisualAbstract: Semaglutide Improves Outcomes in Patients with Obesity-Related Heart Failure Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $6.67 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6

























